Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-β

Science Signaling

Volumn 7, Issue 335, 2014, Pages

  D'Souza, Rochelle C J ^a,e   Knittle, Anna M ^b,c   Nagaraj, Nagarjuna ^a   Van Dinther, Maarten ^b   Choudhary, Chunaram ^a,d   Ten Dijke, Peter ^b   Mann, Matthias ^a,d   Sharma, Kirti ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF TURKU   (Finland)

^d University of Copenhagen   (Denmark)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRG1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GUANINE NUCLEOTIDE BINDING PROTEIN; HUNTINGTIN; INTEGRIN; MINICHROMOSOME MAINTENANCE PROTEIN 6; PHOSPHOPROTEOME; PROLINE RICH PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE B; PROTEIN P53; PROTEOME; RECOMBINANT SOMATOMEDIN C; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMOOTH MUSCLE ACTIN; TATA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; PHOSPHOPROTEIN;

ACTIN FILAMENT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CATION EXCHANGE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DEDIFFERENTIATION; CELL DENSITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA REPLICATION; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; HUMAN CELL; KERATINOCYTE; MISMATCH REPAIR; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; SIGNAL TRANSDUCTION; SPLICEOSOME; TIME SERIES ANALYSIS; TRANSCRIPTION REGULATION; CELL CYCLE CHECKPOINT; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; METABOLISM; TIME;

CELL CYCLE CHECKPOINTS; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; KERATINOCYTES; PHOSPHOPROTEINS; PROTEOME; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84906841343     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004856     Document Type: Article

References (127)

1. J. Massagué, TGFβ in cancer. Cell 134, 215-230 (2008).
2. A. Moustakas, K. Pardali, A. Gaal, C. H. Heldin, Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol. Lett. 82, 85-91 (2002).
3. G. C. Blobe, W. P. Schiemann, H. F. Lodish, Mechanisms of disease: Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358 (2000).
4. J. Massagué, TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630 (2012).
5. R. Kalluri, R. A. Weinberg, The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
6. T. Tsuji, S. Ibaragi, G. F. Hu, Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69, 7135-7139 (2009).
7. C. Scheel, R. A. Weinberg, Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin. Cancer Biol. 22, 396-403 (2012).
8. M. M. Verbeek, I. Otte-Holler, P. Wesseling, D. J. Ruiter, R. M. de Waal, Induction of α-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-β 1. Am. J. Pathol. 144, 372-382 (1994).
9. R. A. Ignotz, J. Massagué, Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261, 4337-4345 (1986).
10. K. Miyazono, Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 314-323 (2009).
11. B. Bierie, H. L. Moses, Tumour microenvironment: TGFβ: The molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506-520 (2006).
12. R. J. Akhurst, R. Derynck, TGF-β signaling in cancer - A double-edged sword. Trends Cell Biol. 11, S44-S51 (2001).
13. J. Zavadil, M. Bitzer, D. Liang, Y. C. Yang, A. Massimi, S. Kneitz, E. Piek, E. P. Bottinger, Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc. Natl. Acad. Sci. U.S.A. 98, 6686-6691 (2001).
14. M. Macías-Silva, S. Abdollah, P. A. Hoodless, R. Pirone, L. Attisano, J. L. Wrana, MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224 (1996).
15. T. Tsukazaki, T. A. Chiang, A. F. Davison, L. Attisano, J. L. Wrana, SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell 95, 779-791 (1998).
16. Y. Zhang, X. Feng, R. We, R. Derynck, Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172 (1996).
17. G. Lagna, A. Hata, A. HemmatiBrivanlou, J. Massagué, Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383, 832-836 (1996).
18. J. Massagué, D. Wotton, Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19, 1745-1754 (2000).
19. K. Luo, S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, Q. Zhou, The Ski oncoprotein interacts with the Smad proteins to repress TGFb signaling. Genes Dev. 13, 2196-2206 (1999).
20. S. Akiyoshi, H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, M. Kawabata, c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J. Biol. Chem. 274, 35269-35277 (1999).
21. K. Pardali, A. Kurisaki, A. Morén, P. ten Dijke, D. Kardassis, A. Moustakas, Role of Smad proteins and transcription factor Sp1 in p21Wafl/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 275, 29244-29256 (2000).
22. G. J. Hannon, D. Beach, p15INK4B is a potential effector of TGF-β-induced cell-cycle arrest. Nature 371, 257-261 (1994).
23. B. A. Hocevar, T. L. Brown, P. H. Howe, TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345-1356 (1999).
24. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, J. M. Gauthier, Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100 (1998).
25. R. A. Ignotz, T. Endo, J. Massagué, Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem. 262, 6443-6446 (1987).
26. Y. E. Zhang, Non-Smad pathways in TGF-β signaling. Cell Res. 19, 128-139 (2009).
27. Y. Mu, S. K. Gudey, M. Landström, Non-Smad signaling pathways. Cell Tissue Res. 347, 11-20 (2012).
28. N. A. Ali, M. J. McKay, M. P. Molloy, Proteomics of Smad4 regulated transforming growth factor-β signalling in colon cancer cells. Mol. Biosyst. 6, 2332-2338 (2010).
29. K. E. Bollinger, J. S. Crabb, X. L. Yuan, T. Putliwala, A. F. Clark, J. W. Crabb, Quantitative proteomics: TGFβ2 signaling in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52, 8287-8294 (2011).
30. N. A. Ali, M. P. Molloy, Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells. Proteomics 11, 3390-3401 (2011).
31. T. Stasyk, A. Dubrovska, M. Lomnytska, I. Yakymovych, C. Wernstedt, C. H. Heldin, U. Hellman, S. Souchelnytskyi, Phosphoproteome profiling of transforming growth factor (TGF)-β signaling: Abrogation of TGFβ1-dependent phosphorylation of transcription factor-II-I (TFII-I) enhances cooperation of TFII-I and Smad3 in transcription. Mol. Biol. Cell 16, 4765-4780 (2005).
32. M. Kato, A. Ishizaki, U. Hellman, C.Wernstedt, M. Kyogoku, K. Miyazono, C. H. Heldin, K. Funa, A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium-and cell density-dependent manner. J. Biol. Chem. 270, 12373-12379 (1995).
33. A. Capone, V. Visco, F. Belleudi, C. Marchese, G. Cardinali, M. Bellocci, M. Picardo, L. Frati, M. R. Torrisi, Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ. 11, 607-614 (2000).
34. J. Cox, M. Y. Hein, C. A. Luber, I. Paron, N. Nagaraj, M. Mann, MaxLFQ allows accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction. Mol. Cell. Proteomics mcp.M113.031591 (2014).
35. M. B. Datto, Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, X. F. Wang, Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 92, 5545-5549 (1995).
36. A. Urruticoechea, I. E. Smith, M. Dowsett, Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23, 7212-7220 (2005).
37. S. T. Eblen, M. P. Fautsch, R. J. Burnette, P. Joshi, E. B. Leof, Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor β1 in cycling epithelial cells. Cell Growth Differ. 5, 109-116 (1994).
38. J. R. Boehm, S. M. Kutz, E. H. Sage, L. Staiano-Coico, P. J. Higgins, Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1. J. Cell. Physiol. 181, 96-106 (1999).
39. C. Margadant, A. Sonnenberg, Integrin -TGF-β crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 11, 97-105 (2010).
40. Q. R. Xi, W. He, X. H. F. Zhang, H. V. Le, J. Massagué, Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor β transcriptional program. J. Biol. Chem. 283, 1146-1155 (2008).
41. M. Fragiadaki, T. Ikeda, A. Witherden, R. M. Mason, D. Abraham, G. Bou-Gharios, High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1. Mol. Biol. Cell 22, 1836-1844 (2011).
42. G. Mengus, A. Fadloun, D. Kobi, C. Thibault, L. Perletti, I. Michel, I. Davidson, TAF4 inactivation in embryonic fibroblasts activates TGFβ signalling and autocrine growth. EMBO J. 24, 2753-2767 (2005).
43. J. S. Munger, X. Z. Huang, H. Kawakatsu, M. J. D. Griffiths, S. L. Dalton, J. F. Wu, J. F. Pittet, N. Kaminski, C. Garat, M. A. Matthay, D. B. Rifkin, D. Sheppard, A mechanism for regulating pulmonary inflammation and fibrosis: The integrin avb 6 binds and activates latent TGFb1. Cell 96, 319- 328 (1999).
44. S. Lamouille, J. Xu, R. Derynck, Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
45. M. Chandra, S. B. Zang, H. Q. Li, L. J. Zimmerman, J. Champer, A. Tsuyada, A. Chow, W. Y. Zhou, Y. Yu, H. Gao, X. B. Ren, R. J. Lin, S. E. Wang, Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing. Mol. Cell. Biol. 32, 2183-2195 (2012).
46. G. Thillainadesan, J. M. Chitilian, M. Isovic, J. N. G. Ablack, J. S. Mymryk, M. Tini, J. Torchia, TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol. Cell 46, 636-649 (2012).
47. J. Cox, M. Mann, 1D and 2D annotation enrichment: A statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 13 (Suppl. 16), S12 (2012).
48. I. H. Chen, H. H. Wang, Y. S. Hsieh, W. C. Huang, H. I. Yeh, Y. J. Chuang, PRSS23 is essential for the Snail-dependent endothelial-to-mesenchymal transition during valvulogenesis in zebrafish. Cardiovasc. Res. 97, 443-453 (2013).
49. R. Samarakoon, J. M. Overstreet, S. P. Higgins, P. J. Higgins, TGF-β1→SMAD/p53/ USF2→PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res. 347, 117-128 (2012).
50. X. S. Gu, L. F. Zerbini, H. H. Otu, M. Bhasin, Q. L. Yang, M. G. Joseph, F. Grall, T. Onatunde, R. G. Correa, T. A. Libermann, Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 67, 4219-4226 (2007).
51. B. Wang, L. E. Lindley, V. Fernandez-Vega, M. E. Rieger, A. H. Sims, K. J. Briegel, The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells. PLOS One 7, e41355 (2012).
52. N. Ding, R. T. Yu, N. Subramaniam, M. H. Sherman, C. Wilson, R. Rao, M. Leblanc, S. Coulter, M. X. He, C. Scott, S. L. Lau, A. R. Atkins, G. D. Barish, J. E. Gunton, C. Liddle, M. Downes, R. M. Evans, A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613 (2013).
53. X. H. Feng, X. Lin, R. Derynck, Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF- b. EMBO J. 19, 5178-5193 (2000).
54. S. E. Ong, B. Blagoev, I. Kratchmarova, D. B. Kristensen, H. Steen, A. Pandey, M. Mann, Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386 (2002).
55. K. Sharma, C. Kumar, G. Kéri, S. B. Breitkopf, F. S. Oppermann, H. Daub, Quantitative analysis of kinase-proximal signaling in lipopolysaccharide-induced innate immune response. J. Proteome Res. 9, 2539-2549 (2010).
56. P. V. Hornbeck, J. M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, B. Murray, V. Latham, M. Sullivan, PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012).
57. S. Abdollah, M. Macias-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, J. L. Wrana, TbRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272, 27678-27685 (1997).
58. S. Souchelnytskyi, K. Tamaki, U. Engstrom, C. Wernstedt, P. ten Dijke, C. H. Heldin, Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem. 272, 28107-28115 (1997).
59. K. S. Choi, Y. W. Eom, Y. Kang, M. J. Ha, H. Rhee, J. W. Yoon, S. J. Kim, Cdc2 and Cdk2 kinase activated by transforming growth factor-β 1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells. J. Biol. Chem. 274, 31775-31783 (1999).
60. F. Das, N. Ghosh-Choudhury, A. Bera, B. S. Kasinath, G. G. Choudhury, TGFβ-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy. J. Cell. Physiol. 228, 1617-1626 (2013).
61. M. C. Wilkes, S. J. Murphy, N. Garamszegi, E. B. Leof, Cell-type-specific activation of PAK2 by transforming growth factor β independent of Smad2 and Smad3. Mol. Cell. Biol. 23, 8878-8889 (2003).
62. G. Chen, X. Chen, A. Sukumar, B. Gao, J. Curley, H. W. Schnaper, A. J. Ingram, J. C. Krepinsky, TGFb receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J. Cell Sci. 126, 3697-3712 (2013).
63. S. Lamouille, E. Connolly, J. W. Smyth, R. J. Akhurst, R. Derynck, TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J. Cell Sci. 125, 1259-1273 (2012).
64. S. Lamouille, R. Derynck, Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol. 178, 437-451 (2007).
65. M. E. Ewen, The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13, 45-66 (1994).
66. G. S. Call, J. Y. Chung, J. A. Davis, B. D. Price, T. S. Primavera, N. C. Thomson, M. V. Wagner, M. D. H. Hansen, Zyxin phosphorylation at serine 142 modulates the zyxin head-tail interaction to alter cell-cell adhesion. Biochem. Biophys. Res. Commun. 404, 780-784 (2011).
67. R. Goel, H. C. Harsha, A. Pandey, T. S. Prasad, Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. Mol. Biosyst. 8, 453-463 (2012).
68. D. Kardassis, C. Murphy, T. Fotsis, A. Moustakas, C. Stournaras, Control of transforming growth factor b signal transduction by small GTPases. FEBS J. 276, 2947-2965 (2009).
69. Y. Katsuno, S. Lamouille, R. Derynck, TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25, 76-84 (2013).
70. N. Colaert, K. Helsens, L. Martens, J. Vandekerckhove, K. Gevaert, Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786-787 (2009).
71. W. Krek, E. A. Nigg, Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell-cycle - Identification of major phosphorylation sites. EMBO J. 10, 305-316 (1991).
72. G. Rodier, P. Coulombe, P. L. Tanguay, C. Boutonnet, S. Meloche, Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APCCdh1 in G1 phase. EMBO J. 27, 679-691 (2008).
73. T. Farkas, K. Hansen, K. Holm, J. Lukas, J. Bartek, Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J. Biol. Chem. 277, 26741-26752 (2002).
74. J. Bartek, J. Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429 (2003).
75. E. M. Kass, J. Ahn, T. Tanaka, W. A. Freed-Pastor, S. Keezer, C. Prives, Stability of checkpoint kinase 2 is regulated via phosphorylation at serine 456. J. Biol. Chem. 282, 30311-30321 (2007).
76. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, J. P. Mesirov, Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550 (2005).
77. M. K. Lee, C. Pardoux, M. C. Hall, P. S. Lee, D. Warburton, J. Qing, S. M. Smith, R. Derynck, TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26, 3957-3967 (2007).
78. M. Yamashita, K. Fatyol, C. Y. Jin, X. C. Wang, Z. G. Liu, Y. E. Zhang, TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol. Cell 31, 918-924 (2008).
79. L. Zhang, F. F. Zhou, A. G. de Vinuesa, E. M. de Kruijf, W. E. Mesker, L. Hui, Y. Drabsch, Y. H. Li, A. Bauer, A. Rousseau, K. A. Sheppard, C. Mickanin, P. J. K. Kuppen, C. X. Lu, P. ten Dijke, TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Mol. Cell 51, 559-572 (2013).
80. A. Moustakas, C. H. Heldin, Non-Smad TGF-β signals. J. Cell Sci. 118, 3573-3584 (2005).
81. A. Franceschini, D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic, A. Roth, J. Y. Lin, P. Minguez, P. Bork, C. von Mering, L. J. Jensen, STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
82. Y. A. Abassi, M. Rehn, N. Ekman, K. Alitalo, K. Vuori, p130Cas couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J. Biol. Chem. 278, 35636-35643 (2003).
83. L. Davis, K. Abdi, M. Machius, C. Brautigam, D. R. Tomchick, V. Bennett, P. Michaely, Localization and structure of the ankyrin-binding site on β2-spectrin. J. Biol. Chem. 284, 6982-6987 (2009).
84. N. Manchanda, A. Lyubimova, H. Y. Ho, M. F. James, J. F. Gusella, N. Ramesh, S. B. Snapper, V. Ramesh, The NF2 tumor suppressor Merlin and the ERM proteins interact with N-WASP and regulate its actin polymerization function. J. Biol. Chem. 280, 12517-12522 (2005).
85. S. J. Smith, R. O. McCann, A C-terminal dimerization motif is required for focal adhesion targeting of Talin1 and the interaction of the Talin1 I/LWEQ module with F-actin. Biochemistry 46, 10886-10898 (2007).
86. R. Uribe, D. Jay, A review of actin binding proteins: New perspectives. Mol. Biol. Rep. 36, 121-125 (2009).
87. M. Deckers, M. van Dinther, J. Buijs, N. Que, C. Lowik, G. van der Pluijm, P. ten Dijke, The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209 (2006).
88. D. D. Bickle, Y. Oda, Z. Xie, Vitamin D and skin cancer: A problem in gene regulation. J. Steroid Biochem. Mol. Biol. 97, 83-91 (2005).
89. M. Xiong, J. B. Gong, Y. H. Liu, R. Xiang, X. Y. Tan, Loss of vitamin D receptor in chronic kidney disease: A potential mechanism linking inflammation to epithelial-to-mesenchymal transition. Am. J. Physiol. Renal Physiol. 303, F1107-F1115 (2012).
90. S. Sarkar, D. W. Leaman, S. Gupta, P. Sil, D. Young, A. Morehead, D. Mukherjee, N. Ratliff, Y. P. Sun, M. Rayborn, J. Hollyfield, S. Sen, Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. J. Biol. Chem. 279, 20422-20434 (2004).
91. G. M. Di Guglielmo, C. Le Roy, A. F. Goodfellow, J. L. Wrana, Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat. Cell Biol. 5, 410-421 (2003).
92. F. Palacios, J. S. Tushir, Y. Fujita, C. D' Souza-Schorey, Lysosomal targeting of E-cadherin: A unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol. Cell. Biol. 25, 389-402 (2005).
93. M. C. Jones, P. T. Caswell, J. C. Norman, Endocytic recycling pathways: Emerging regulators of cell migration. Curr. Opin. Cell Biol. 18, 549-557 (2006).
94. Y. X. Feng, E. S. Sokol, C. A. Del Vecchio, S. Sanduja, J. H. Claessen, T. A. Proia, D. X. Jin, F. Reinhardt, H. L. Ploegh, Q. Wang, P. B. Gupta, Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress. Cancer Discov. 4, 702-715 (2014).
95. A. Iavarone, J. Massagué, Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417-422 (1997).
96. M. Lemaire, C. Froment, R. Boutros, O. Mondesert, A. R. Nebreda, B. Monsarrat, B. Ducommun, CDC25B phosphorylation by p38 and MK-2. Cell Cycle 5, 1649-1653 (2006).
97. A. Errico, K. Deshmukh, Y. Tanaka, A. Pozniakovsky, T. Hunt, Identification of substrates for cyclin dependent kinases. Adv. Enzyme Regul. 50, 375-399 (2010).
98. A. Iavarone, J. Massagué, E2F and histone deacetylase mediate transforming growth factor β repression of cdc25A during keratinocyte cell cycle arrest. Mol. Cell. Biol. 19, 916-922 (1999).
99. C. Jacob, H. Grabner, S. Atanasoski, U. Suter, Expression and localization of Ski determine cell type - specific TGFβ signaling effects on the cell cycle. J. Cell Biol. 182 519-530 (2008).
100. M. A. Bjornsti, P. J. Houghton, Lost in translation: Dysregulation of cap-dependent translation and cancer. Cancer Cell 5, 519-523 (2004).
101. N. Sonenberg, A. Pause, Signal transduction: Protein synthesis and oncogenesis meet again. Science 314, 428-429 (2006).
102. R. Azar, A. Alard, C. Susini, C. Bousquet, S. Pyronnet, 4E-BP1 is a target of Smad4 essential for TGFβ-mediated inhibition of cell proliferation. EMBO J. 28, 3514-3522 (2009).
103. M. Kato, H. Yuan, Z. G. Xu, L. Lanting, S. L. Li, M. Wang, M. C. Hu, M. A. Reddy, R. Natarajan, Role of the Akt/FoxO3a pathway in TGF-β1-mediated mesangial cell dysfunction: A novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 17, 3325-3335 (2006).
104. D. D. De Mesquita, Q. Zhan, L. Crossley, J. A. Badwey, p90-RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant-stimulated neutrophils. FEBS Lett. 502, 84-88 (2001).
105. C. Sutherland, I. A. Leighton, P. Cohen, Inactivation of glycogen-synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth-factor signaling. Biochem. J. 296, 15-19 (1993).
106. C. Xu, N. G. Kim, B. M. Gumbiner, Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 8, 4032-4039 (2009).
107. G. Zhu, Y. Wang, B. Huang, J. Liang, Y. Ding, A. Xu, W. Wu, A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells. Oncogene 31, 1001-1012 (2012).
108. I. Shin, A. V. Bakin, U. Rodeck, A. Brunet, C. L. Arteaga, Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol. Biol. Cell 12, 3328-3339 (2001).
109. J. W. Poulsen, C. T. Madsen, C. Young, F. M. Poulsen, M. L. Nielsen, Using guanidine-hydrochloride for fast and efficient protein digestion and single-step affinity-purification mass spectrometry. J. Proteome Res. 12, 1020-1030 (2013).
110. N. A. Kulak, G. Pichler, I. Paron, N. Nagaraj, M. Mann, Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat. Methods 11, 319-324 (2014).
111. J. V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, M. Mann, Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (2006).
112. N. Nagaraj, R. C. J. D'Souza, J. Cox, J. V. Olsen, M. Mann, Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J. Proteome Res. 9, 6786-6794 (2010).
113. J. R. Wisniewski, A. Zougman, N. Nagaraj, M. Mann, Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362 (2009).
114. S. A. Beausoleil, M. Jedrychowski, D. Schwartz, J. E. Elias, J. Villén, J. Li, M. A. Cohn, L. C. Cantley, S. P. Gygi, Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. U.S.A. 101, 12130-12135 (2004).
115. J. Rappsilber, Y. Ishihama, M. Mann, Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663- 670 (2003).
116. A. Michalski, E. Damoc, J. P. Hauschild, O. Lange, A.Wieghaus, A. Makarov, N. Nagaraj, J. Cox, M. Mann, S. Horning, Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, M111.011015 (2011).
117. J. Cox, M. Mann, MaxQuant enables high peptide identification rates, individualized p.p.b.- range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
118. J. Cox, N. Neuhauser, A. Michalski, R. A. Scheltema, J. V. Olsen, M. Mann, Andromeda: A peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
119. M. Magrane, U. Consortium, UniProt Knowledgebase: A hub of integrated protein data. Database 2011, bar009 (2011).
120. T. Geiger, A. Wehner, C. Schaab, J. Cox, M. Mann, Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell. Proteomics 11, M111.014050 (2012).
121. V. G. Tusher, R. Tibshirani, G. Chu, Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 5116-5121 (2001).
122. M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, G. Sherlock, Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
123. M. Kanehisa, S. Goto, S. Kawashima, A. Nakaya, The KEGG databases at GenomeNet. Nucleic Acids Res. 30, 42-46 (2002).
124. D. A. Hosack, G. Dennis, B. T. Sherman, H. C. Lane, R. A. Lempicki, Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70 (2003).
125. A. Krämer, J. Green, J. Pollard Jr., S. Tugendreich, Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523-530 (2014).
126. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
127. L. Zhang, H. Z. Huang, F. F. Zhou, J. Schimmel, C. G. Pardo, T. T. Zhang, T. S. Barakat, K. A. Sheppard, C. Mickanin, J. A. Porter, A. C. O. Vertegaal, H. van Dam, J. Gribnau, C. X. Lu, P. ten Dijke, RNF12 controls embryonic stem cell fate and morphogenesis in zebrafish embryos by targeting Smad7 for degradation. Mol. Cell 47, 330 (2012) [published erratum appears in Mol. Cell 46, 650 (2012)].